NULOJIX subst sèche 250 mg 2 flac
7680615210044
CH-61521
L04AA28
07.15.0.
Reimbursement limitations:
NULOJIX
Pour la prévention d’un rejet d’un organe (greffon/tranplant) après une allogreffe (tranplantation) rénale chez les …
1 / 3
google
Details
- Product number
- 6152101
- CPT
- -
- Packaging group
- 2
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: belataceptum 250 mg, saccharum, natrii dihydrogenophosphas monohydricus, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, pro vitro corresp. natrium max. 13 mg.
Articles (1)
Nulojix 250 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 868.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2023
Authorization holder
Bristol-Myers Squibb SA
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 61521
- Drug name
- Nulojix, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L04AA28
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 15/12/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NULOJIX subst sèche 250 mg 2 flac
- Description (DE)
- NULOJIX Trockensub 250 mg 2 Durchstf
- Market launch
- 15/12/2011
- Narcotic (BTM)
- No